The activated transcription factor ERα plays an important role in the breast development and progression of cancer. In a non-classical pathway ER interacts with other transcription factors AP-1, NFkB, SP1, etc. AP-1 transcription factors control rapid responses of mammalian cells to stimuli that impact proliferation, differentiation, and transformation. AP-1 factors are leucine zipper proteins belonging to members of the Jun family (c-Jun, JunB, and JunD) and Fos family (c-Fos, FosB, Fra-1, and Fra-2) proteins. Although AP-1 factors are well characterized, not much is known about the expression pattern of the AP-1 factors in breast cancer cells. Hence to determine which AP-1 factors are expressed and regulated by estrogen, we used human br...
HMG-CoA reductase inhibitors, such as Lovastatin and Simvastatin, cause cell cycle arrest by interfe...
Background The activator protein-1 (AP-1) transcription factor is believed to be imp...
Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast cancer. Endocr...
Abstract C-Fos and c-Jun are transcription factors that form the dimer Activator Protein 1 (AP-1) an...
International audienceTo explore the mechanisms whereby estrogen and antiestrogen (tamoxifen (TAM)) ...
Estrogens promote breast tumorigenesis by binding to estrogen receptors (ERs), encoded by two genes,...
My thesis research involved studying hormonal modulation of gene expression in three different cases...
Studies indicate that estrogen receptor (ER) mediates breast cancer-promoting effects of estrogens...
To functionally analyze the role of AP-2γ as an ERα cofactor in breast cancer, we focused on exa...
Lifetime exposure to estrogens is an established risk factor for developing breast cancer. Estradiol...
Breast cancer is the most common malignancy in women in the Western world, accounting for 18% of all...
Abstract Background Signaling pathways that converge on two different transcription factor complexes...
Breast cancer is the most common cause of cancer among women in most countries (WHO). Ovarian hormon...
International audienceAlthough many studies reported mechanisms involved in the positive regulation ...
It has been established that ZFP36 (also known as Tristetraprolin or TTP) promotes mRNA degradation ...
HMG-CoA reductase inhibitors, such as Lovastatin and Simvastatin, cause cell cycle arrest by interfe...
Background The activator protein-1 (AP-1) transcription factor is believed to be imp...
Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast cancer. Endocr...
Abstract C-Fos and c-Jun are transcription factors that form the dimer Activator Protein 1 (AP-1) an...
International audienceTo explore the mechanisms whereby estrogen and antiestrogen (tamoxifen (TAM)) ...
Estrogens promote breast tumorigenesis by binding to estrogen receptors (ERs), encoded by two genes,...
My thesis research involved studying hormonal modulation of gene expression in three different cases...
Studies indicate that estrogen receptor (ER) mediates breast cancer-promoting effects of estrogens...
To functionally analyze the role of AP-2γ as an ERα cofactor in breast cancer, we focused on exa...
Lifetime exposure to estrogens is an established risk factor for developing breast cancer. Estradiol...
Breast cancer is the most common malignancy in women in the Western world, accounting for 18% of all...
Abstract Background Signaling pathways that converge on two different transcription factor complexes...
Breast cancer is the most common cause of cancer among women in most countries (WHO). Ovarian hormon...
International audienceAlthough many studies reported mechanisms involved in the positive regulation ...
It has been established that ZFP36 (also known as Tristetraprolin or TTP) promotes mRNA degradation ...
HMG-CoA reductase inhibitors, such as Lovastatin and Simvastatin, cause cell cycle arrest by interfe...
Background The activator protein-1 (AP-1) transcription factor is believed to be imp...
Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast cancer. Endocr...